Clinical Trials Conference 2020

The 4th annual Clinical Trials Conference entitled "Patient Group Pathway Model to Accessing Clinical Trials and Real-World Evidence Methodologies with a special focus on precision medicine" was held on October 21, 2020. It brought together key stakeholders including researchers, clinical trial networks, patients, patient groups, government agencies and industry to reinforce patient and patient group partnerships among those who advocate for cancer clinical trials in Canada. Acknowledging the evolutionary trends in the field of precision medicine, the conference provided insight to the dynamics of patient-centricity and value-based care as adapted to new trial designs.

Session 1: Intro and KEYNOTE International Regulatory Collaboration in the era of Precision Medicine

Speakers: Dr. Steven Lemery (FDA), Melissa Hunt (Health Canada)

Panel:Barry Stein (CCC), Anne Marie Wright (ESI)

Session 3: Frameworks for RWE and Recommendations for Real World Endpoints

Speakers: Dr. Margaret McCusker (Flatiron), Dr. James Creeden (Foundation Medicine)

Panel:Dr. Michael Duong (Roche), Anne Marie Wright (ESI)

Session 4: Digital Health Technology in Modernizing Clinical Trials

Speakers: Dr. Kam Kafi (Imagia AI), Dr. Mackenzie Wildman (Evidation Health), Aaron Leibtag (Pentavere AI)

Panel: Stephen Sundquist (3CTN), Barry Stein (CCC), Anne Marie Wright (ESI)

Session 5: Clinical Trial Considerations and using RWD/RWE to help inform Value Based Agreements

Speakers: Murray Aitken (IQVIA), Dr. Michael Seewald (AstraZeneca), Dr. Christopher McCabe (Institute of Health Economics)

Panel: Leigh Funston (AstraZeneca Canada), Anne Marie Wright (ESI)

Session 6: The CTTI Model – Canadian Cancer Clinical Trials Stakeholder Charter and Meeting Wrap Up

Speakers:Stephen Sundquist (3CTN), Judy Needham (Canadian Cancer Trials Group)

Panel: Vatche Bartekian (Vantage BioTrials), Martine Elias (Myeloma Canada), Dr. Stephanie Michaud (BioCanRx), Anne Marie Wright (ESI)